S&P 500   4,203.77 (+0.57%)
DOW   32,984.75 (+0.23%)
QQQ   349.31 (+0.38%)
AAPL   179.02 (+1.00%)
MSFT   328.30 (-0.03%)
META   270.82 (+2.30%)
GOOGL   123.18 (+0.25%)
AMZN   121.64 (+0.88%)
TSLA   202.79 (-0.56%)
NVDA   391.30 (+3.43%)
NIO   7.44 (-1.20%)
BABA   82.99 (+4.32%)
AMD   118.09 (-0.10%)
T   15.75 (+0.13%)
F   12.03 (+0.25%)
MU   68.79 (+0.87%)
CGC   0.85 (+1.80%)
GE   103.91 (+2.34%)
DIS   88.18 (+0.25%)
AMC   4.61 (+2.44%)
PFE   38.03 (+0.03%)
PYPL   62.78 (+1.27%)
NFLX   399.74 (+1.14%)
S&P 500   4,203.77 (+0.57%)
DOW   32,984.75 (+0.23%)
QQQ   349.31 (+0.38%)
AAPL   179.02 (+1.00%)
MSFT   328.30 (-0.03%)
META   270.82 (+2.30%)
GOOGL   123.18 (+0.25%)
AMZN   121.64 (+0.88%)
TSLA   202.79 (-0.56%)
NVDA   391.30 (+3.43%)
NIO   7.44 (-1.20%)
BABA   82.99 (+4.32%)
AMD   118.09 (-0.10%)
T   15.75 (+0.13%)
F   12.03 (+0.25%)
MU   68.79 (+0.87%)
CGC   0.85 (+1.80%)
GE   103.91 (+2.34%)
DIS   88.18 (+0.25%)
AMC   4.61 (+2.44%)
PFE   38.03 (+0.03%)
PYPL   62.78 (+1.27%)
NFLX   399.74 (+1.14%)
S&P 500   4,203.77 (+0.57%)
DOW   32,984.75 (+0.23%)
QQQ   349.31 (+0.38%)
AAPL   179.02 (+1.00%)
MSFT   328.30 (-0.03%)
META   270.82 (+2.30%)
GOOGL   123.18 (+0.25%)
AMZN   121.64 (+0.88%)
TSLA   202.79 (-0.56%)
NVDA   391.30 (+3.43%)
NIO   7.44 (-1.20%)
BABA   82.99 (+4.32%)
AMD   118.09 (-0.10%)
T   15.75 (+0.13%)
F   12.03 (+0.25%)
MU   68.79 (+0.87%)
CGC   0.85 (+1.80%)
GE   103.91 (+2.34%)
DIS   88.18 (+0.25%)
AMC   4.61 (+2.44%)
PFE   38.03 (+0.03%)
PYPL   62.78 (+1.27%)
NFLX   399.74 (+1.14%)
S&P 500   4,203.77 (+0.57%)
DOW   32,984.75 (+0.23%)
QQQ   349.31 (+0.38%)
AAPL   179.02 (+1.00%)
MSFT   328.30 (-0.03%)
META   270.82 (+2.30%)
GOOGL   123.18 (+0.25%)
AMZN   121.64 (+0.88%)
TSLA   202.79 (-0.56%)
NVDA   391.30 (+3.43%)
NIO   7.44 (-1.20%)
BABA   82.99 (+4.32%)
AMD   118.09 (-0.10%)
T   15.75 (+0.13%)
F   12.03 (+0.25%)
MU   68.79 (+0.87%)
CGC   0.85 (+1.80%)
GE   103.91 (+2.34%)
DIS   88.18 (+0.25%)
AMC   4.61 (+2.44%)
PFE   38.03 (+0.03%)
PYPL   62.78 (+1.27%)
NFLX   399.74 (+1.14%)
NASDAQ:CYRX

Cryoport (CYRX) Stock Forecast, Price & News

$18.54
+0.13 (+0.71%)
(As of 11:02 AM ET)
Compare
Today's Range
$18.01
$18.56
50-Day Range
$18.41
$24.00
52-Week Range
$15.63
$45.36
Volume
18,316 shs
Average Volume
386,696 shs
Market Capitalization
$844.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$29.50

Cryoport MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
60.2% Upside
$29.50 Price Target
Short Interest
Bearish
8.22% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.10mentions of Cryoport in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$3.88 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.64) to ($0.42) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.05 out of 5 stars

Transportation Sector

80th out of 123 stocks

Pharmaceutical Preparations Industry

287th out of 492 stocks


CYRX stock logo

About Cryoport (NASDAQ:CYRX) Stock

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

Receive CYRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter.

CYRX Stock News Headlines

Cryoport's Tumble Isn't Over Yet
Cryoport (NASDAQ:CYRX) Shares Down 7.4%
AI is Unstoppable. Now Is The Time!
AI, or Artificial Intelligence, is all the rage right now. AI technologies are empowering users in every industry to increase sales, efficiency, and productivity. It's truly a case of adapt or fail.
CryoPort (CYRX) Rose on Revenue Guidance
8-K: Cryoport, Inc.
AI is Unstoppable. Now Is The Time!
AI, or Artificial Intelligence, is all the rage right now. AI technologies are empowering users in every industry to increase sales, efficiency, and productivity. It's truly a case of adapt or fail.
Cryoport Reports First Quarter 2023 Results
Macroeconomic Headwinds Dragged Cryoport (CYRX) in Q4
Cryoport Reports Fourth Quarter and Full Year 2022 Results
When Will Cryoport, Inc. (NASDAQ:CYRX) Become Profitable?
See More Headlines

CYRX Price History

CYRX Company Calendar

Last Earnings
5/04/2023
Today
6/01/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRX
Employees
1,024
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$29.50
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$28.00
Forecasted Upside/Downside
+60.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-37,330,000.00
Pretax Margin
-10.94%

Debt

Sales & Book Value

Annual Sales
$237.28 million
Book Value
$11.86 per share

Miscellaneous

Free Float
40,763,000
Market Cap
$835.66 million
Optionable
Optionable
Beta
1.32

Key Executives

  • Jerrell W. SheltonJerrell W. Shelton
    Chairman, President & Chief Executive Officer
  • Robert S. StefanovichRobert S. Stefanovich
    Chief Financial Officer, Secretary & Treasurer
  • Mark W. SawickiMark W. Sawicki
    Chief Scientific Officer
  • Thomas J. Heinzen
    Vice President-Corporate Development













CYRX Stock - Frequently Asked Questions

Should I buy or sell Cryoport stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CYRX shares.
View CYRX analyst ratings
or view top-rated stocks.

What is Cryoport's stock price forecast for 2023?

4 Wall Street analysts have issued 1 year price targets for Cryoport's shares. Their CYRX share price forecasts range from $28.00 to $30.00. On average, they anticipate the company's share price to reach $29.50 in the next twelve months. This suggests a possible upside of 60.8% from the stock's current price.
View analysts price targets for CYRX
or view top-rated stocks among Wall Street analysts.

How have CYRX shares performed in 2023?

Cryoport's stock was trading at $17.35 at the beginning of the year. Since then, CYRX shares have increased by 5.8% and is now trading at $18.35.
View the best growth stocks for 2023 here
.

When is Cryoport's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our CYRX earnings forecast
.

How were Cryoport's earnings last quarter?

Cryoport, Inc. (NASDAQ:CYRX) announced its earnings results on Thursday, May, 4th. The consumer goods maker reported ($0.16) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.02. The consumer goods maker earned $62.82 million during the quarter, compared to analyst estimates of $62.15 million. Cryoport had a negative trailing twelve-month return on equity of 4.90% and a negative net margin of 11.91%. The firm's revenue for the quarter was up 20.1% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.31) EPS.

What ETFs hold Cryoport's stock?

ETFs with the largest weight of Cryoport (NASDAQ:CYRX) stock in their portfolio include Principal Healthcare Innovators ETF (BTEC), Pacer Industrials and Logistics ETF (SHPP),

What guidance has Cryoport issued on next quarter's earnings?

Cryoport updated its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $270.00 million-$290.00 million, compared to the consensus revenue estimate of $273.56 million.

What other stocks do shareholders of Cryoport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Block (SQ).

What is Cryoport's stock symbol?

Cryoport trades on the NASDAQ under the ticker symbol "CYRX."

Who are Cryoport's major shareholders?

Cryoport's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Brown Capital Management LLC (16.44%), BlackRock Inc. (6.96%), Impax Asset Management Group plc (5.54%), Fred Alger Management LLC (5.30%), Macquarie Group Ltd. (3.08%) and Macquarie Group Ltd. (3.08%). Insiders that own company stock include Daniel M Hancock, Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman, Robert J Hariri and Robert Stefanovich.
View institutional ownership trends
.

How do I buy shares of Cryoport?

Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cryoport's stock price today?

One share of CYRX stock can currently be purchased for approximately $18.35.

How much money does Cryoport make?

Cryoport (NASDAQ:CYRX) has a market capitalization of $835.66 million and generates $237.28 million in revenue each year. The consumer goods maker earns $-37,330,000.00 in net income (profit) each year or ($0.78) on an earnings per share basis.

How many employees does Cryoport have?

The company employs 1,024 workers across the globe.

How can I contact Cryoport?

Cryoport's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The official website for the company is www.cryoport.com. The consumer goods maker can be reached via phone at (949) 470-2300, via email at tfromer@kcsa.com, or via fax at 949-470-2306.

This page (NASDAQ:CYRX) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -